Clinical Trial Update: Biomarkers of Mild and Moderate Traumatic Brain Injury

View source ↗

Summary

This clinical trial update reports on a completed study evaluating biomarkers in mild and moderate traumatic brain injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: Banyan Biomarkers, Inc | Conditions: Brain Injuries, Traumatic | Status: COMPLETED